Infectious Diseases News and Research

RSS

MR Solutions installs 3T PET-MR system at Western University’s ImPaKT facility

MR Solutions has installed a 3T PET-MR preclinical imaging system at Western University’s one of a kind ImPaKT Laboratory in Ontario.

From MR Solutions 5 Feb 2020

Epiglottitis linked to teenager's use of e-cigarettes

A teenage girl with no hint of prior asthma or respiratory illness began to feel hoarseness in her throat and a feeling that she needed to clear her throat frequently.

5 Feb 2020

Study may suggest new therapeutic approaches to control immune responses

Researchers have provided new insight on the role of cyclic AMP (cAMP) in regulating the immune response.

5 Feb 2020

Spread of coronavirus extends far beyond Wuhan and other quarantined cities

Infectious disease researchers at The University of Texas at Austin and other institutions in Hong Kong, mainland China and France have concluded there is a high probability that the deadly Wuhan coronavirus spread beyond Wuhan and other quarantined cities before Chinese officials were able to put a quarantine in place.

5 Feb 2020

Hendra antibody trial shows promise in a world-first human clinical trial

The Hendra virus is a potent pathogen transmitted to humans from animals that cause a severe and often fatal illness in both infected horses and humans. Originating from fruit bats, the virus caused an outbreak in Australia in 1994.

4 Feb 2020

Promising HIV vaccine fails in a large-scale clinical trial

The human immune deficiency virus (HIV) is an infectious disease that can lead to immunosuppression called acquired immunodeficiency syndrome (AIDS). For decades, scientists race to discover a vaccine that can help prevent the spread of the virus. The latest trial testing a new experimental vaccine in South Africa end in disappointment after deeming ineffective in preventing infection.

4 Feb 2020

Coronavirus could be dangerous for vulnerable populations, says UGA epidemiologist

Wearing a surgical mask is unlikely to protect healthy people from the novel coronavirus that originated in China, and influenza likely poses a much greater threat to Americans, according to José Cordero, professor of epidemiology and biostatistics in the University of Georgia's College of Public Health.

4 Feb 2020

UH professor examines life cycle of drug-resistant persister cells in recurrent infections

A University of Houston engineering professor is examining the life cycle of stubborn, drug-resistant persister cells in recurrent infections to find a way to destroy them.

4 Feb 2020

First responders need to take special precautions to protect themselves from coronavirus

Healthcare personnel working on the front lines to contain and prevent the spread of the new coronavirus that originated in China need to take special, yet common, precautions to keep themselves and others safe.

3 Feb 2020

Women’s Heart Fund announces launch of ‘Community Conversations with the CDI’

The Women's Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor 'Community Conversations with the CDI,' a women-focused, three-year lecture series featuring researchers from Hackensack Meridian Health's Center for Discovery and Innovation.

3 Feb 2020

Investigational HIV vaccine not effective in preventing HIV

The National Institute of Allergy and Infectious Diseases), part of the National Institutes of Health, has stopped administration of vaccinations in its HVTN 702 clinical trial of an investigational HIV vaccine.

3 Feb 2020

Experimental vaccine prevents infection of lung and nasal cavity

Researchers have found that viruses causing human respiratory infections called human metapneumovirus (HMPV) have a special ability to hide itself from the body’s immune system. This prevents the body from fighting the infection off. This very strategy has been used in development of a vaccine against HMPV say the researchers.

3 Feb 2020

Experimental vaccine could be effective against both Zika and Dengue

Walter Reed army institute of research has shown that a new vaccine against the Zika virus could be effective against both Zika and dengue virus. The study titled, “Potent Zika and dengue cross-neutralizing antibodies induced by Zika vaccination in a dengue experienced donor,” in the latest issue of the journal Nature Medicine.

3 Feb 2020

Coronavirus taking an economic toll on China

The novel coronavirus or 2019-nCoV outbreak has negatively impacted the economy of China and other countries worldwide. With China’s isolation from other countries and travel bans imposed, the economic toll is rippling across the world.

3 Feb 2020

Multimodal analysis of tumors could give new insights into treating cancer patients

Melding the genetic and cellular analysis of tumors with how they appear in medical images could give physicians and other cancer therapy specialists new insights into how to best treat patients, especially those with brain cancer, according to a new study led by the Translational Genomics Research Institute, an affiliate of City of Hope.

31 Jan 2020

First exposure to influenza virus dictates our lifelong ability to fight flu

Were you born in an H1N1 year or an H3N2 year? The first type of influenza virus we are exposed to in early childhood dictates our ability to fight the flu for the rest of our lives, according to a new study from a team of infectious disease researchers at McMaster University and Université de Montréal.

30 Jan 2020

State-purchased insurance plans improve HIV outcomes, save healthcare costs

Health insurance purchased by state AIDS Drug Assistance Programs for people living with HIV in states that did not expand Medicaid are improving outcomes and have the potential to save millions in healthcare costs, a new study suggests.

30 Jan 2020

Research uncovers how HIV develops resistance to key drugs

The mechanism behind how HIV can develop resistance to a widely-prescribed group of drugs has been uncovered by new research from the Crick and Dana-Farber Cancer Institute, with the findings opening the door to the development of more effective treatments.

30 Jan 2020

Wuhan coronavirus is genetically different from human SARS, MERS-CoV, study found

The Wuhan coronavirus or the 2019-nCoV or novel coronavirus is a new human-infecting coronavirus genetically different from human SARS (Severe Acute Respiratory Syndrome), and MERS-CoV (Middle East Respiratory Syndrome), a team of scientists has found.

30 Jan 2020